+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gemfibrozil"

Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Fibrate Drugs Market Report 2025 - Product Thumbnail Image

Fibrate Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Gemfibrozil is a lipid-lowering medication used to treat high cholesterol and triglyceride levels in the blood. It is a member of the fibrate class of drugs, which are used to reduce the risk of cardiovascular disease. Gemfibrozil works by increasing the breakdown of triglycerides in the liver, reducing the amount of fat in the blood. It also increases the production of HDL (good) cholesterol, which helps to reduce the risk of heart disease. Gemfibrozil is often prescribed in combination with other cholesterol-lowering medications, such as statins. The market for Gemfibrozil is highly competitive, with many pharmaceutical companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies, such as Mylan and Teva, also offer generic versions of the drug. Show Less Read more